C. auris can cause large outbreaks in healthcare facilities. As of April 30, there have been 684 cases of C. auris in the U.S., in addition to numerous cases reported globally. Learning how the fungus spreads can help clinicians stem the worldwide outbreaks.
Researchers found that patients can have high concentrations of C. auris on their skin and developed methods of counting the fungus in samples collected from patients’ skin and their rooms. The beds of patients with higher C. auris concentrations on their skin also had higher levels of C. auris.
The researchers cultured live C. auris from the beds of all patients who tested positive for C. auris, and even from the beds that were formally occupied by C. auris patients.
“This finding supported our hypothesis that patients are actively shedding C. auris cells into their environment,” said Joe Sexton, PhD, a post-doctoral fellow at the CDC who led the study.
The research was presented at ASM Microbe, the annual meeting of the American Society for Microbiology that ends June 24 in San Francisco.
More articles on healthcare quality:
Colorado Springs hospital shooting leaves 2 dead
Universal ‘holy grail’ flu vaccine could be in sight
9 states where minors can get vaccinated without parental consent
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
